Position | R&D experience | Availability FTE | ||||||||||||||||||||
Since | No of protocols | Countries | Indications | Services | Audits/inspections | |||||||||||||||||
Therapy | Surgery | Devices | Vaccines | Oncology | Project Management | Medical writing | Feasibility | Submissions | Contracts | Monitoring | Co-Monitoring | Site Management | Site Coordination | Sponsor | FDA | EMA | Local CA/DP | |||||
Manager | 1999 | >100 | LTU, LAT, EST, SWE, NOR, GBR, GRE, HUN, BLR | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | >20 | 3 | 1 | 3 | 0.25 | |
Sr CRA | 2004 | >50 | LTU, LAT, EST, UKR, ITA, FRA, GBR | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | >10 | 1 | 2 | 0.5 | ||||
Sr CRA | 2005 | 29 | LTU | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | 0 | |||||||||
CRA | 2006 | >15 | LTU, LAT, UKR, SWE, RUS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | 1 | 0,6 | |||||||
Sr CRA | 2006 | 29 | LTU, LAT, EST, UKR | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 10 | 1 | 0.5 | |||||||
CR Consultant | 2007 | >30 | LTU, LAT, BLR, AUS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | >10 | 2 | 2 | 0,4 | ||||||
Sr CRA | 2007 | >40 | LTU | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | 0.5 | |||||||||
Sr CRA | 2009 | >20 | LTU, LAT, RUS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 3 | 0 | ||||||
CTA | 2018 | 2 | LTU | ✓ | ✓ | 0.75 |